Browse Topic
Diabetes and Endocrinology
-
March 10, 2026UC Davis Health opens obesity clinic
The Division of Endocrinology has opened an obesity clinic offering comprehensive treatment to address genetic, hormonal and environmental factors related to weight gain.
Read More
-
December 05, 2025UC Davis Health examines systemic impact of GLP-1–based therapies
UC Davis Health is exploring the potential of GLP-1 agonists with a new Obesity Clinic and a recent gathering of experts who research the systemic effect of the drugs.
Read More
-
September 26, 2025Inside UC Davis Health’s new approach to obesity care
Endocrinologist Miranda Stiewig-Rapp discussed current trends in obesity treatment, including GLP-1 agonists, potential benefits of intermittent fasting and personalized approaches to obesity care.
Read More
-
July 29, 2025UC Davis Medical Center ranked as top hospital in the Sacramento region
UC Davis Medical Center is the No. 1 hospital in the Sacramento region and No. 7 in California, according to U.S. News & World Report.
Read More
-
April 03, 2025UC Davis Health launches new cell therapy trial for chronic kidney disease patients
A new clinical trial at UC Davis Health is investigating cell therapy for patients with Chronic Kidney Disease caused by type 2 diabetes.
Read More
-
February 10, 2025With AI, a new 'metabolic watchdog' takes diabetes care from burden to balance
Living with Type 1 diabetes requires continuous upkeep of glucose and minute-to-minute management, an impossibility for most young adults. Sam King, an associate professor of computer science, hopes to ease the daily mental load of diabetes with BeaGL, an AI-driven, customizable care system.
Read More
-
November 26, 2024Study uncovers how chronic kidney disease impacts glucose and glycemic control
A new study from researchers at UC Davis Health reveals how complications from chronic kidney disease are linked to problems in the metabolic system.
Read More
-
July 23, 20243 ways to improve diabetes care through telehealth
Researchers asked clinicians and staff how telehealth is used in their clinic, the challenges they have faced, helpful practices and plans for the future.
Read More -
July 16, 2024U.S. News ranks UC Davis Medical Center among nation’s best
U.S. News and World Report has once again ranked UC Davis Medical Center among the nation’s best in its prestigious best hospitals survey.
Read More
-
April 19, 20243 ways to improve diabetes care through telehealth
Researchers asked clinicians and staff how telehealth is used in their clinic, the challenges they have faced, helpful practices and plans for the future.
Read More
-
February 26, 2024Diabetes and endocrinology programs listed among top in the nation
Becker's Hospital Review listed UC Davis Health in its first edition of hospitals and health systems with “great diabetes and endocrinology programs.”
Read More
-
January 09, 2024Why SGLT2 inhibitors should be stopped before surgery
UC Davis Health’s endocrinology team has published a case study that highlights how important it is for providers to stop SGLT2 inhibitors three days before a scheduled surgery.
Read More
-
October 24, 2023Study shows thyroid cancer is more common among transgender female veterans
A study by endocrinology researchers shows a high prevalence of thyroid cancer among transgender female veterans, the first evidence of such a disparity.
Read More
-
July 25, 2023Inpatient glycemic team improves outcomes for patients with diabetes and hyperglycemia
By utilizing an active, at-the-bedside consultation service, the inpatient glycemic team has improved outcomes for hospitalized patients with hyperglycemia and diabetes.
Read More
-
January 19, 2023UC Davis Health awarded nearly $4 million to study models of obesity and diabetes
UC Davis Health’s Department of Surgery has received a multimillion dollar grant to establish a National Center for Metabolic Phenotyping of Mouse Models of Obesity and Diabetes.
Read More
-
September 21, 2022UC Davis researchers explore new angle on pancreatic islet function
UC Davis researchers have shown for the first time that the signaling protein 14-3-3-zeta can shift pancreatic alpha cells from producing glucagon, which increases blood glucose, to make the antidiabetic hormone GLP-1. These findings could lead to new therapies for people with type 2 diabetes.
Read More